Allevion Therapeutics is an early stage company focused on developing a novel smart wearable-tech device that reduces hand and leg tremor, specifically Essential Tremor (ET). This first-to-market, lightweight smart cuff delivers a non-invasive energy-based therapy to alter the activity of nerves responsible for the tremor.
Allevx Smartcuff Technology allows patients to regain confidence and significantly improves their quality of life. This breakthrough energy system has the potential to address ET and other movement related disorders such as Parkinson's disease (PD) and Dystonia.
Our board of directors is comprised of a a proven management team with several successful exits in medical device and technology fields.MEET THE TEAM
Allevion Therapeutics was incorporated in 2017 in Delaware and filed multiple patent applications covering broad method and techniques for Class II devices.
Allevion Therapeutics completed seed funding in 2018 followed by recent Series A funding in July 2021